These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8029886)

  • 61. Regulation of the activity of graft survival-prolonging bone marrow cells.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):271-2. PubMed ID: 2650117
    [No Abstract]   [Full Text] [Related]  

  • 62. Persistent expression of donor antigens in endothelium of long-standing skin xenografts and vulnerability to destruction by specific antibodies.
    Bogman MJ; de Waal RM; Koene RA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):205-7. PubMed ID: 3274773
    [No Abstract]   [Full Text] [Related]  

  • 63. Prolongation of xenograft survival by combining donor-specific intravenous presensitization with FK 506.
    Iwata H; Umeda Y; Matsuno Y; Yoshikawa S; Marui T; Miyauchi T; Takagi H; Mori Y; Hirose H
    Transplant Proc; 2002 Nov; 34(7):2745-8. PubMed ID: 12431592
    [No Abstract]   [Full Text] [Related]  

  • 64. Correlation of xenografting results using different organ systems: differential value of xenograft organ testing.
    Thomas F; Araneda D; Pittman K; Marchman W; DeMasi R; Quarantillo P; Thomas J
    Transplant Proc; 1992 Apr; 24(2):525-6. PubMed ID: 1566416
    [No Abstract]   [Full Text] [Related]  

  • 65. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
    Jeannet M; Vaucher A; Gervasoni C
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
    [No Abstract]   [Full Text] [Related]  

  • 66. Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats.
    Tashiro H; Shintaku S; Fudaba Y; Yamamoto H; Shibata S; Mizunuma K; Okimasa S; Marubayashi S; Fukuda Y; Dohi K; Asahara T
    Transplant Proc; 2000 Nov; 32(7):2363-4. PubMed ID: 11120201
    [No Abstract]   [Full Text] [Related]  

  • 67. Lymphocyte ecology and immunologic tolerance.
    Levey RH
    Transplant Proc; 1973 Mar; 5(1):893-6. PubMed ID: 4572152
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of timing of bone marrow injection on the prolongation of skin grafts in ALS-treated mice.
    Hartner WC; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):242-3. PubMed ID: 2650110
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of antilymphocytic and antimacrophagic sera on the survival time of skin xenotransplants in mice].
    Khundanov LL; Nastoiashchaia NN; Verbitskiĭ MSh; Kipervasser EM; Kirzon SS
    Patol Fiziol Eksp Ter; 1972; 16(5):47-52. PubMed ID: 4596808
    [No Abstract]   [Full Text] [Related]  

  • 70. Dependence of antilymphocyte serum effectiveness on degree of donor-recipient histocompatibility.
    Silberman H; Reckard CR; Klinman N; Barker CF
    Surg Forum; 1972; 23(0):303-5. PubMed ID: 4601092
    [No Abstract]   [Full Text] [Related]  

  • 71. Selective lymphoid irradiation. II. Prolongation of cardiac xenografts and allografts in presensitized rats.
    Hardy MA; Oluwole S; Fawwaz R; Satake K; Nowygrod R; Reemtsma K
    Transplantation; 1982 Mar; 33(3):237-42. PubMed ID: 7039032
    [No Abstract]   [Full Text] [Related]  

  • 72. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts.
    Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803
    [No Abstract]   [Full Text] [Related]  

  • 73. Importance of schedule of administration of adjunctive, short-term immunosuppression in ALS- and bone marrow cell-treated, skin-allografted mice.
    Gozzo JJ; Plowey J; Hartner WC; De Fazio SR
    Transplant Proc; 1995 Feb; 27(1):169-70. PubMed ID: 7878958
    [No Abstract]   [Full Text] [Related]  

  • 74. Expression of MHC class II antigen is essential in tolerance induction by donor bone marrow cell in antilymphocyte serum-treated and rapamycin-treated mice.
    Umemura A; Monaco AP; Maki T
    Transplant Proc; 2001; 33(1-2):148. PubMed ID: 11266751
    [No Abstract]   [Full Text] [Related]  

  • 75. [The use of antithymocyte serum for prolonging the survival time of xenogenic skin grafts].
    Zhao XF
    Zhonghua Wai Ke Za Zhi; 1982 Nov; 20(11):671-4, 702. PubMed ID: 6763556
    [No Abstract]   [Full Text] [Related]  

  • 76. Bone marrow in bone versus bone marrow cell suspension transplant.
    Olszewski WL; Lukomska B; Durlic M; Ziembinski A
    Transplant Proc; 1992 Dec; 24(6):3002-3. PubMed ID: 1466034
    [No Abstract]   [Full Text] [Related]  

  • 77. Exceptionally long survival time in xenogeneic organ transplantation.
    Hammer C; Chaussy C; Welter H; Wembacher J; Höbel G; Brendel W
    Transplant Proc; 1981 Mar; 13(1 Pt 2):881-4. PubMed ID: 6455827
    [No Abstract]   [Full Text] [Related]  

  • 78. Induction of donor-specific hyporeactivity in augmented microchimerism in rat liver transplantation followed by donor bone marrow.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Shintaku S; Ohdan H; Miyata H; Dohi K
    Transplant Proc; 1997; 29(1-2):1196-7. PubMed ID: 9123269
    [No Abstract]   [Full Text] [Related]  

  • 79. Oral delivery of xenoantigen combined with non-depleting anti-CD4 monoclonal antibody induced significant prolonged survival of concordant skin xenografts.
    Niimi M; Shirasugi N; Hamano K; Esato K; Matsumoto K; Ikeda Y; Shatari T; Takami H; Kodaira S
    Transplant Proc; 2000 Aug; 32(5):1035. PubMed ID: 10936338
    [No Abstract]   [Full Text] [Related]  

  • 80. Genetic control of allograft tolerance: importance of H-2 subregions.
    Click RE; Cahill G; Condie RM; Azar MM; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):582-5. PubMed ID: 7022894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.